0000921895-21-000601.txt : 20210302 0000921895-21-000601.hdr.sgml : 20210302 20210302173653 ACCESSION NUMBER: 0000921895-21-000601 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210226 FILED AS OF DATE: 20210302 DATE AS OF CHANGE: 20210302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wang Luhua CENTRAL INDEX KEY: 0001847910 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36866 FILM NUMBER: 21705481 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics Inc. CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-514-7149 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Summit Therapeutics plc DATE OF NAME CHANGE: 20150219 FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 4 1 form412566002_03022021.xml OWNERSHIP DOCUMENT X0306 4 2021-02-26 0 0001599298 Summit Therapeutics Inc. SMMT 0001847910 Wang Luhua C/O SUMMIT THERAPEUTICS INC., ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 1 0 0 0 Stock Option (right to buy) 6.77 2021-02-26 4 A 0 70000 6.77 A 2031-02-26 Common Stock 70000 70000 D Stock Option (right to buy) 6.77 2021-02-28 4 A 0 21096 6.77 A 2031-02-28 Common Stock 21096 91096 D The option was granted on February 26, 2021. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on February 26, 2022. The option was granted on February 28, 2021 and represents a pro rata amount of the annual 25,000 option board grant based on the number of days this year the reporting person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2021. /s/ Michael Paul Donaldson, Attorney-in-Fact 2021-03-02